PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128018
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128018
Canine Stem Cell Therapy Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034
Growth Factors of canine stem cell therapy Market
The global canine stem cell therapy market was valued at USD 58.0 million in 2025 and is expected to reach USD 67.0 million in 2026. The market is forecast to grow substantially and attain USD 220.0 million by 2034, registering a robust CAGR of 16.02% during the forecast period (2026-2034). The increasing prevalence of osteoarthritis, hip dysplasia, ligament injuries, and chronic inflammatory conditions in dogs, coupled with growing pet ownership and rising expenditure on advanced veterinary healthcare, is fueling market expansion. In 2025, North America dominated the global market with a 41.37% share, supported by strong pet healthcare spending and early adoption of regenerative veterinary medicine.
Canine stem cell therapy involves the use of stem cell-based products, cell processing systems, banking services, and treatment procedures designed specifically for dogs. These therapies help reduce inflammation, promote tissue regeneration, improve mobility, and enhance the quality of life for companion animals suffering from chronic orthopedic and inflammatory disorders.
Advancements in Cell Processing Technologies Driving Market Growth
Technological progress in stem cell processing is emerging as a major trend within the canine stem cell therapy market. Improvements in cell isolation, expansion, cryopreservation, quality testing, and GMP-compliant manufacturing have significantly enhanced treatment consistency and effectiveness. These advancements enable the development of reliable autologous and allogeneic stem cell therapies that can be commercialized on a larger scale.
The growing availability of ready-to-use stem cell products is reducing treatment preparation times and improving accessibility for veterinary clinics and specialty hospitals. In March 2025, VetStem Biopharma secured strategic funding to support the final stages of U.S. FDA conditional approval for StemStat Ortho, an off-the-shelf stem cell therapy developed for canine osteoarthritis.
Growing Awareness of Regenerative Veterinary Medicine Boosting Demand
Increasing awareness regarding regenerative medicine among veterinarians and pet owners is one of the primary factors driving market growth. Stem cell therapy is increasingly recognized as an effective alternative to traditional pain management and surgical interventions for chronic canine conditions.
Pet owners are becoming more willing to invest in advanced therapies that improve mobility, comfort, and long-term health outcomes for aging dogs. Educational initiatives from veterinary hospitals, clinical studies, and industry participants are also contributing to wider adoption. In April 2025, VetStem reported processing more than 40,000 stem cell treatments across the U.S. and Canada, demonstrating growing confidence in regenerative therapies.
Regulatory Challenges Continue to Restrict Expansion
Despite strong growth potential, the market faces regulatory challenges. Veterinary stem cell therapies are subject to varying regulations across different countries, creating complexities for product approval and commercialization. In the U.S., stem cell products may be regulated as new animal drugs, requiring extensive documentation, safety evaluations, and manufacturing compliance.
The lack of harmonized global regulations increases development costs and extends approval timelines, limiting the number of commercially available products and slowing market penetration.
Rising Veterinary Healthcare Spending Creating Opportunities
Growing expenditure on companion animal healthcare presents significant opportunities for market participants. Pet owners increasingly view dogs as family members and are willing to spend more on advanced treatments that improve long-term wellbeing.
Stem cell therapy is gaining traction for treating osteoarthritis, ligament injuries, hip dysplasia, and chronic inflammatory disorders. According to the American Pet Products Association, the U.S. pet industry generated USD 158 billion in 2025, highlighting the strong financial foundation supporting advanced veterinary treatments and regenerative medicine solutions.
High Treatment Costs Remain a Key Challenge
One of the major barriers to broader adoption is the high cost of treatment. Stem cell therapy procedures often involve consultation, diagnostics, anesthesia, tissue harvesting, laboratory processing, cell injections, and follow-up rehabilitation, resulting in substantial expenses for pet owners.
Limited insurance reimbursement for regenerative therapies further increases out-of-pocket costs. As a result, adoption remains concentrated among specialty veterinary hospitals and higher-income pet owners. Reducing processing costs and expanding insurance coverage will be critical to supporting wider acceptance.
Segmental Analysis
Based on therapy type, the market is segmented into autologous, allogeneic, and others. The autologous segment dominated the market in 2025, driven by the widespread use of stem cells derived from a dog's own adipose tissue. This approach minimizes the risk of immune rejection and has gained strong acceptance among veterinarians. The allogeneic segment is projected to register the fastest growth, expanding at a CAGR of 20.72% through 2034 due to the increasing availability of ready-to-use therapies.
By disease indication, the orthopedic and musculoskeletal segment led the market in 2025 and is expected to account for 72.7% of market share in 2026. High prevalence of osteoarthritis, joint pain, tendon injuries, and hip dysplasia among aging dogs continues to drive demand. The dermatology and skin inflammation segment is anticipated to record the highest CAGR of 24.44% during the forecast period.
Based on end user, veterinary clinics dominated the market in 2025 and are expected to hold 32.3% market share in 2026 due to their broad accessibility and ability to coordinate stem cell therapy workflows efficiently. Veterinary orthopedic and rehabilitation centers are projected to grow at a CAGR of 17.68% through 2034.
Regional Insights
North America remained the leading regional market, reaching USD 24.0 million in 2025. Strong pet ownership rates, advanced veterinary infrastructure, and early adoption of regenerative medicine continue to support regional growth. The U.S. market is projected to reach USD 25.6 million in 2026, representing approximately 38.2% of global revenues.
Europe is expected to grow at a CAGR of 15.59%, supported by increasing acceptance of regenerative therapies and favorable veterinary healthcare systems. Germany and the U.K. remain key regional contributors.
Asia Pacific is projected to reach USD 13.6 million in 2026, driven by rising pet adoption, growing disposable income, and increasing demand for premium veterinary care in countries such as China, Japan, Australia, South Korea, and India.
Competitive Landscape
The market is moderately consolidated, with leading companies focusing on autologous stem cell processing, cell banking services, and development of ready-to-use allogeneic therapies. Key companies include VetStem, Inc., EquiCord, Ardent Animal Health LLC, Bioceltix S.A., Gallant, StemcellX, Cell Therapy Sciences Ltd., Animacel, Enovis (Companion Animal Health), and JangoPet LLC.
Recent developments include Bioceltix's large-scale manufacturing facility approval in February 2026, Gallant's USD 18 million Series B funding round in June 2025, and ongoing clinical advancements in stem cell therapies for canine osteoarthritis and atopic dermatitis.
Conclusion
The global canine stem cell therapy market is poised for substantial expansion, growing from USD 58.0 million in 2025 to USD 67.0 million in 2026, and reaching USD 220.0 million by 2034. Rising awareness of regenerative veterinary medicine, increasing pet healthcare expenditure, technological advancements in stem cell processing, and growing demand for non-surgical treatment options are expected to drive market growth. While regulatory complexities and high treatment costs remain challenges, continuous innovation and expanding clinical acceptance will support the long-term development of the canine stem cell therapy industry.
Segmentation By Therapy Type, Disease Indication, End User, and Region
By Therapy Type * Autologous
- Allogeneic
- Others
By Disease Indication * Orthopedic & Musculoskeletal
- Dermatology & Skin Inflammation
- Neurology
- Immune & Inflammatory Disorders
- Oral/Dental
- Ophthalmic
- Reproductive & Urogenital
- Others
By End User * Veterinary Specialty Hospitals
- Veterinary Clinics
- Veterinary Ortho/Rehab Centers
- Academic & Research Institutes
- Veterinary Regenerative Medicine Centers
- Others
By Region * North America (By Therapy Type, Disease Indication, End User, and Country)
- U.S.
- Canada
- Europe (By Therapy Type, Disease Indication, End User, and Country/Sub-region)
- Germany
- U.K.
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific (By Therapy Type, Disease Indication, End User, and Country/Sub-region)
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Therapy Type, Disease Indication, End User, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Therapy Type, Disease Indication, End User, and Country/Sub-region)
- GCC
- South Africa
- Rest of Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 3.5. Market Challenges
4. Key Insights
- 4.1. Technological Advancements in Canine Stem Cell Therapy Market
- 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
- 4.3. New Product Launches, By Key Players
- 4.4. Regulatory Scenario, By Key Countries/Regions
- 4.5. Reimbursement Scenario, By Key Countries/Regions
5. Global Canine Stem Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Therapy Type
- 5.1.1. Autologous
- 5.1.2. Allogeneic
- 5.1.3. Others
- 5.2. Market Analysis, Insights and Forecast - By Disease Indication
- 5.2.1. Orthopedic & Musculoskeletal
- 5.2.2. Dermatology & Skin Inflammation
- 5.2.3. Neurology
- 5.2.4. Immune & Inflammatory Disorders
- 5.2.5. Oral/Dental
- 5.2.6. Ophthalmic
- 5.2.7. Reproductive & Urogenital
- 5.2.8. Others
- 5.3. Market Analysis, Insights and Forecast - By End User
- 5.3.1. Veterinary Specialty Hospitals
- 5.3.2. Veterinary Clinics
- 5.3.3. Veterinary Ortho/Rehab Centers
- 5.3.4. Academic & Research Institutes
- 5.3.5. Veterinary Regenerative Medicine Centers
- 5.3.6. Others
- 5.4. Market Analysis, Insights and Forecast - Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Canine Stem Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Therapy Type
- 6.1.1. Autologous
- 6.1.2. Allogeneic
- 6.1.3. Others
- 6.2. Market Analysis, Insights and Forecast - By Disease Indication
- 6.2.1. Orthopedic & Musculoskeletal
- 6.2.2. Dermatology & Skin Inflammation
- 6.2.3. Neurology
- 6.2.4. Immune & Inflammatory Disorders
- 6.2.5. Oral/Dental
- 6.2.6. Ophthalmic
- 6.2.7. Reproductive & Urogenital
- 6.2.8. Others
- 6.3. Market Analysis, Insights and Forecast - By End User
- 6.3.1. Veterinary Specialty Hospitals
- 6.3.2. Veterinary Clinics
- 6.3.3. Veterinary Ortho/Rehab Centers
- 6.3.4. Academic & Research Institutes
- 6.3.5. Veterinary Regenerative Medicine Centers
- 6.3.6. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Canine Stem Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Therapy Type
- 7.1.1. Autologous
- 7.1.2. Allogeneic
- 7.1.3. Others
- 7.2. Market Analysis, Insights and Forecast - By Disease Indication
- 7.2.1. Orthopedic & Musculoskeletal
- 7.2.2. Dermatology & Skin Inflammation
- 7.2.3. Neurology
- 7.2.4. Immune & Inflammatory Disorders
- 7.2.5. Oral/Dental
- 7.2.6. Ophthalmic
- 7.2.7. Reproductive & Urogenital
- 7.2.8. Others
- 7.3. Market Analysis, Insights and Forecast - By End User
- 7.3.1. Veterinary Specialty Hospitals
- 7.3.2. Veterinary Clinics
- 7.3.3. Veterinary Ortho/Rehab Centers
- 7.3.4. Academic & Research Institutes
- 7.3.5. Veterinary Regenerative Medicine Centers
- 7.3.6. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
8. Asia Pacific Canine Stem Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Therapy Type
- 8.1.1. Autologous
- 8.1.2. Allogeneic
- 8.1.3. Others
- 8.2. Market Analysis, Insights and Forecast - By Disease Indication
- 8.2.1. Orthopedic & Musculoskeletal
- 8.2.2. Dermatology & Skin Inflammation
- 8.2.3. Neurology
- 8.2.4. Immune & Inflammatory Disorders
- 8.2.5. Oral/Dental
- 8.2.6. Ophthalmic
- 8.2.7. Reproductive & Urogenital
- 8.2.8. Others
- 8.3. Market Analysis, Insights and Forecast - By End User
- 8.3.1. Veterinary Specialty Hospitals
- 8.3.2. Veterinary Clinics
- 8.3.3. Veterinary Ortho/Rehab Centers
- 8.3.4. Academic & Research Institutes
- 8.3.5. Veterinary Regenerative Medicine Centers
- 8.3.6. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America Canine Stem Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Therapy Type
- 9.1.1. Autologous
- 9.1.2. Allogeneic
- 9.1.3. Others
- 9.2. Market Analysis, Insights and Forecast - By Disease Indication
- 9.2.1. Orthopedic & Musculoskeletal
- 9.2.2. Dermatology & Skin Inflammation
- 9.2.3. Neurology
- 9.2.4. Immune & Inflammatory Disorders
- 9.2.5. Oral/Dental
- 9.2.6. Ophthalmic
- 9.2.7. Reproductive & Urogenital
- 9.2.8. Others
- 9.3. Market Analysis, Insights and Forecast - By End User
- 9.3.1. Veterinary Specialty Hospitals
- 9.3.2. Veterinary Clinics
- 9.3.3. Veterinary Ortho/Rehab Centers
- 9.3.4. Academic & Research Institutes
- 9.3.5. Veterinary Regenerative Medicine Centers
- 9.3.6. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
10. Middle East & Africa Canine Stem Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Therapy Type
- 10.1.1. Autologous
- 10.1.2. Allogeneic
- 10.1.3. Others
- 10.2. Market Analysis, Insights and Forecast - By Disease Indication
- 10.2.1. Orthopedic & Musculoskeletal
- 10.2.2. Dermatology & Skin Inflammation
- 10.2.3. Neurology
- 10.2.4. Immune & Inflammatory Disorders
- 10.2.5. Oral/Dental
- 10.2.6. Ophthalmic
- 10.2.7. Reproductive & Urogenital
- 10.2.8. Others
- 10.3. Market Analysis, Insights and Forecast - By End User
- 10.3.1. Veterinary Specialty Hospitals
- 10.3.2. Veterinary Clinics
- 10.3.3. Veterinary Ortho/Rehab Centers
- 10.3.4. Academic & Research Institutes
- 10.3.5. Veterinary Regenerative Medicine Centers
- 10.3.6. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. VetStem, Inc.
- 11.2.2. EquiCord
- 11.2.3. Ardent Animal Health, LLC
- 11.2.4. Bioceltix S.A.
- 11.2.5. Gallant
- 11.2.6. StemcellX
- 11.2.7. Cell Therapy Sciences Ltd.
- 11.2.8. Animacel
- 11.2.9. Enovis (Companion Animal Health)
- 11.2.10. JangoPet, LLC.
List of Tables
- Table 1: Global Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By Therapy Type, 2021-2034
- Table 2: Global Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By Disease Indication, 2021-2034
- Table 3: Global Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By End User, 2021-2034
- Table 4: Global Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By Region, 2021-2034
- Table 5: North America Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By Therapy Type, 2021-2034
- Table 6: North America Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By Disease Indication, 2021-2034
- Table 7: North America Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By End User, 2021-2034
- Table 8: North America Canine Stem Cell Therapy Market Revenue (USD million) Forecast, by Country, 2021-2034
- Table 9: Europe Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By Therapy Type, 2021-2034
- Table 10: Europe Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By Disease Indication, 2021-2034
- Table 11: Europe Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By End User, 2021-2034
- Table 12: Europe Canine Stem Cell Therapy Market Revenue (USD million) Forecast, by Country/ Sub-region, 2021-2034
- Table 13: Asia Pacific Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By Therapy Type, 2021-2034
- Table 14: Asia Pacific Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By Disease Indication, 2021-2034
- Table 15: Asia Pacific Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By End User, 2021-2034
- Table 16: Asia Pacific Canine Stem Cell Therapy Market Revenue (USD million) Forecast, by Country/ Sub-region, 2021-2034
- Table 17: Latin America Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By Therapy Type, 2021-2034
- Table 18: Latin America Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By Disease Indication, 2021-2034
- Table 19: Latin America Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By End User, 2021-2034
- Table 20: Latin America Canine Stem Cell Therapy Market Revenue (USD million) Forecast, by Country/ Sub-region, 2021-2034
- Table 21: Middle East & Africa Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By Therapy Type, 2021-2034
- Table 22: Middle East & Africa Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By Disease Indication, 2021-2034
- Table 23: Middle East & Africa Canine Stem Cell Therapy Market Revenue (USD million) Forecast, By End User, 2021-2034
- Table 24: Middle East & Africa Canine Stem Cell Therapy Market Revenue (USD million) Forecast, by Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Canine Stem Cell Therapy Market Revenue Breakdown (USD million, %) By Region, 2025 & 2034
- Figure 2: Global Canine Stem Cell Therapy Market Value Share (%), By Therapy Type, 2025 & 2034
- Figure 3: Global Canine Stem Cell Therapy Market Value Share (%), By Disease Indication, 2025 & 2034
- Figure 4: Global Canine Stem Cell Therapy Market Value Share (%), By End User, 2025 & 2034
- Figure 5: Global Canine Stem Cell Therapy Market Value Share (%), By Region, 2025 & 2034
- Figure 6: North America Canine Stem Cell Therapy Market Value (USD million), By Therapy Type, 2025 & 2034
- Figure 7: North America Canine Stem Cell Therapy Market Value Share (%), By Therapy Type, 2025
- Figure 8: North America Canine Stem Cell Therapy Market Value (USD million), By Disease Indication, 2025 & 2034
- Figure 9: North America Canine Stem Cell Therapy Market Value Share (%), By Disease Indication, 2025
- Figure 10: North America Canine Stem Cell Therapy Market Value (USD million), By End User, 2025 & 2034
- Figure 11: North America Canine Stem Cell Therapy Market Value Share (%), By End User, 2025
- Figure 12: North America Canine Stem Cell Therapy Market Value (USD million), by Country, 2025 & 2034
- Figure 13: North America Canine Stem Cell Therapy Market Value Share (%), by Country, 2025
- Figure 14: Europe Canine Stem Cell Therapy Market Value (USD million), By Therapy Type, 2025 & 2034
- Figure 15: Europe Canine Stem Cell Therapy Market Value Share (%), By Therapy Type, 2025
- Figure 16: Europe Canine Stem Cell Therapy Market Value (USD million), By Disease Indication, 2025 & 2034
- Figure 17: Europe Canine Stem Cell Therapy Market Value Share (%), By Disease Indication, 2025
- Figure 18: Europe Canine Stem Cell Therapy Market Value (USD million), By End User, 2025 & 2034
- Figure 19: Europe Canine Stem Cell Therapy Market Value Share (%), By End User, 2025
- Figure 20: Europe Canine Stem Cell Therapy Market Value (USD million), by Country/ Sub-region, 2025 & 2034
- Figure 21: Europe Canine Stem Cell Therapy Market Value Share (%), by Country/ Sub-region, 2025
- Figure 22: Asia Pacific Canine Stem Cell Therapy Market Value (USD million), By Therapy Type, 2025 & 2034
- Figure 23: Asia Pacific Canine Stem Cell Therapy Market Value Share (%), By Therapy Type, 2025
- Figure 24: Asia Pacific Canine Stem Cell Therapy Market Value (USD million), By Disease Indication, 2025 & 2034
- Figure 25: Asia Pacific Canine Stem Cell Therapy Market Value Share (%), By Disease Indication, 2025
- Figure 26: Asia Pacific Canine Stem Cell Therapy Market Value (USD million), By End User, 2025 & 2034
- Figure 27: Asia Pacific Canine Stem Cell Therapy Market Value Share (%), By End User, 2025
- Figure 28: Asia Pacific Canine Stem Cell Therapy Market Value (USD million), by Country/ Sub-region, 2025 & 2034
- Figure 29: Asia Pacific Canine Stem Cell Therapy Market Value Share (%), by Country/ Sub-region, 2025
- Figure 30: Latin America Canine Stem Cell Therapy Market Value (USD million), By Therapy Type, 2025 & 2034
- Figure 31: Latin America Canine Stem Cell Therapy Market Value Share (%), By Therapy Type, 2025
- Figure 32: Latin America Canine Stem Cell Therapy Market Value (USD million), By Disease Indication, 2025 & 2034
- Figure 33: Latin America Canine Stem Cell Therapy Market Value Share (%), By Disease Indication, 2025
- Figure 34: Latin America Canine Stem Cell Therapy Market Value (USD million), By End User, 2025 & 2034
- Figure 35: Latin America Canine Stem Cell Therapy Market Value Share (%), By End User, 2025
- Figure 36: Latin America Canine Stem Cell Therapy Market Value (USD million), by Country/ Sub-region, 2025 & 2034
- Figure 37: Latin America Canine Stem Cell Therapy Market Value Share (%), by Country/ Sub-region, 2025
- Figure 38: Middle East & Africa Canine Stem Cell Therapy Market Value (USD million), By Therapy Type, 2025 & 2034
- Figure 39: Middle East & Africa Canine Stem Cell Therapy Market Value Share (%), By Therapy Type, 2025
- Figure 40: Middle East & Africa Canine Stem Cell Therapy Market Value (USD million), By Disease Indication, 2025 & 2034
- Figure 41: Middle East & Africa Canine Stem Cell Therapy Market Value Share (%), By Disease Indication, 2025
- Figure 42: Middle East & Africa Canine Stem Cell Therapy Market Value (USD million), By End User, 2025 & 2034
- Figure 43: Middle East & Africa Canine Stem Cell Therapy Market Value Share (%), By End User, 2025
- Figure 44: Middle East & Africa Canine Stem Cell Therapy Market Value (USD million), by Country/ Sub-region, 2025 & 2034
- Figure 45: Middle East & Africa Canine Stem Cell Therapy Market Value Share (%), by Country/ Sub-region, 2025
- Figure 46: Global Canine Stem Cell Therapy Market Share (%), by Company, 2025
